DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5z974p/hemoglobinopathies) has announced the addition of the "Hemoglobinopathies - Pipeline Review, H2 2013" report to their offering.
'Hemoglobinopathies - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hemoglobinopathies, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemoglobinopathies.
- A snapshot of the global therapeutic scenario for Hemoglobinopathies.
- A review of the Hemoglobinopathies products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hemoglobinopathies pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Some Key Topics Covered:
Pipeline Products for Hemoglobinopathies - Overview
Pipeline Products for Hemoglobinopathies - Comparative Analysis
Hemoglobinopathies - Therapeutics under Development by Companies
Hemoglobinopathies - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Hemoglobinopathies - Products under Development by Companies
Hemoglobinopathies - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Therapeutic Class
NiCord - Drug Profile
ZFP Transcription Factors For Hemoglobinopathies - Drug Profile
ALN-TMP - Drug Profile
Drug Targeting PRMT5 - Drug Profile
Drug Targeting Protein Arginine Methyltransferase 5 - Drug Profile
Hemoglobinopathies - Recent Pipeline Updates
Hemoglobinopathies - Product Development Milestones
Sangamo BioSciences, Inc.
Gamida Cell Ltd.
Alnylam Pharmaceuticals, Inc.
Cancer Therapeutics CRC Pty Ltd
For more information visit http://www.researchandmarkets.com/research/5z974p/hemoglobinopathies
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.